TCS 21311 manufacturers
- TCS 21311
-
- $44.00
-
2026-07-27
- CAS:1260181-14-3
- Purity: 99.39%
- Supply Ability: 10g
|
| | TCS 21311 Basic information |
| Product Name: | TCS 21311 | | Synonyms: | 3-[5-[4-(2-Hydroxy-2-Methyl-1-oxopropyl)-1-piperazinyl]-2-(trifluoroMethyl)phenyl]-4-(1H-indol-3-yl)-1H-pyrrole-2,5-dione;TCS 21311;TCS21311; TCS-21311;JAK3/GSK-3β/PKCα Inhibitor - CAS 1260181-14-3 - Calbiochem;3-{5-[4-(2-hydroxy-2-methylpropionyl)piperazin-1-yl]-2-trifluoromethylphenyl}-4-(1H-indol-3-yl)pyrrole-2,5-dione;1H-Pyrrole-2,5-dione, 3-[5-[4-(2-hydroxy-2-methyl-1-oxopropyl)-1-piperazinyl]-2-(trifluoromethyl)phenyl]-4-(1H-indol-3-yl)-;Protein kinase C,TCS 21311,Glycogen synthase kinase 3,NIBR 3049,TCS21311,GSK-3,Glycogen synthase kinase-3,Inhibitor,JAK,inhibit,NIBR-3049,TCS-21311,Janus kinase,PKC;3-(5-(4-(2-Hydroxy-2-methylpropanoyl)piperazin-1-yl)-2-(trifluoromethyl)phenyl)-4-(1H-indol-3-yl)-1H-pyrrole-2,5-dione | | CAS: | 1260181-14-3 | | MF: | C27H25F3N4O4 | | MW: | 526.51 | | EINECS: | | | Product Categories: | Aromatics;Heterocycles;Inhibitors;Intermediates & Fine Chemicals;Pharmaceuticals | | Mol File: | 1260181-14-3.mol |  |
| | TCS 21311 Chemical Properties |
| Boiling point | 793.0±60.0 °C(Predicted) | | density | 1.436±0.06 g/cm3(Predicted) | | storage temp. | +2C to +8C | | solubility | <52.65mg/ml in DMSO | | form | Yellow solid | | pka | 7.91±0.60(Predicted) | | color | White to yellow | | InChIKey | CLGRAWDGLMENOD-UHFFFAOYSA-N | | SMILES | O=C1NC(C(C2=CNC3=C2C=CC=C3)=C1C4=CC(N5CCN(C(C(C)(C)O)=O)CC5)=CC=C4C(F)(F)F)=O |
| WGK Germany | WGK 3 | | Storage Class | 11 - Combustible Solids |
| | TCS 21311 Usage And Synthesis |
| Uses | A potent JAK3 inhibitor; selective for JAK3 over JAK1, JAK2 and TYK2. It also inhibits GSK-3β, PKCα and PKCθ. | | Biological Activity | tcs 21311 is a potent and selective jak3 inhibitor with the ic50 values of 8 nm. tcs 21311 shows high selectivity for jak3 over jak1, jak2 and tyk2. the ic50 values are 1017, 2550 and 8055 nm respectively. tcs 21311 exihibits inhibitory effect on gsk-3β, pkcα and pkcθ with the ic50 values of 3, 13 and 68 nm, respectively [1].janus kinases (jak) belong to a small family of cytoplasmic protein tyrosine kinases including jak1, jak2, tyk2, and jak3, which play important roles in initiating the cytokine-triggered signaling events by activators of transcription (stat) proteins via tyrosine phosphorylation [2]. due to its association with relevant cytokine signaling pathways, jak3 serves as an important target for therapeutic intervention in the treatment of inflammatory diseases, autoimmune disorders and organ transplant rejection [2]. | | IC 50 | JAK3: 8 nM (IC50); JAK2: 2.55 μM (IC50); JAK1: 1.017 μM (IC50); PKCα: 13 nM (IC50); PKCθ: 68 nM (IC50); GSK-3β: 3 nM (IC50) | | storage | Desiccate at RT | | references | [1] thoma g, nuninger f, falchetto r, et al. identification of a potent janus kinase 3 inhibitor with high selectivity within the janus kinase family[j]. journal of medicinal chemistry, 2010, 54(1): 284-288.
[2] clark m p, george k m, bookland r g, et al. development of new pyrrolopyrimidine-based inhibitors of janus kinase 3 (jak3)[j]. bioorganic & medicinal chemistry letters, 2007, 17(5): 1250-1253. |
| | TCS 21311 Preparation Products And Raw materials |
|